Insider · CIK 0001304404

Perier Francis I Jr

Reports to the SEC for 3 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001304404

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-07-01	SpringWorks Therapeutics, Inc.D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−60.9K sh	—	—	0
2025-07-01	SpringWorks Therapeutics, Inc.Performance Share UnitsD Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−14.7K sh	—	—	0
2025-07-01	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−369K sh	—	—	0
2025-07-01	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−75K sh	—	—	0
2025-07-01	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−125K sh	—	—	0
2025-07-01	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−60K sh	—	—	0
2025-07-01	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−34.4K sh	—	—	0
2025-01-10	SpringWorks Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+11.8K sh	—	—	60,889
2025-01-10	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+34.4K sh	—	—	34,419
2025-01-06	SpringWorks Therapeutics, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−3,283 sh	$38.86	−$128K	49,110
2025-01-05	SpringWorks Therapeutics, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−3,278 sh	$38.19	−$125K	52,393
2025-01-04	SpringWorks Therapeutics, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−3,582 sh	$38.19	−$137K	55,671
2024-01-08	SpringWorks Therapeutics, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−3,215 sh	$41.53	−$134K	59,253
2024-01-05	SpringWorks Therapeutics, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−2,151 sh	$37.96	−$81.7K	62,468
2024-01-04	SpringWorks Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+21.2K sh	—	—	64,619
2024-01-04	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+60K sh	—	—	60,000
2023-01-07	SpringWorks Therapeutics, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−1,090 sh	$26.41	−$28.8K	43,463
2023-01-06	SpringWorks Therapeutics, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−2,374 sh	$27.52	−$65.3K	44,553
2023-01-05	SpringWorks Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+19.4K sh	—	—	46,927
2023-01-05	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+60K sh	—	—	60,000
2023-01-05	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+65K sh	—	—	65,000
2022-01-07	SpringWorks Therapeutics, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−1,846 sh	$56.06	−$103K	26,963
2022-01-07	SpringWorks Therapeutics, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−1,307 sh	$56.06	−$73.3K	27,502
2022-01-06	SpringWorks Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+18.8K sh	—	—	28,809
2022-01-06	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+58.6K sh	—	—	58,622
2021-01-07	SpringWorks Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+10K sh	—	—	10,000
2021-01-07	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+80K sh	—	—	80,000
2020-03-02	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+75K sh	—	—	75,000
2014-07-01	Forest Laboratories, LLCD Disposition to Issuer	EVP - Chief Financial Officer	DDisposition to Issuer	−62.1K sh	—	—	0
2014-07-01	Forest Laboratories, LLCD Disposition to Issuer	EVP - Chief Financial Officer	DDisposition to Issuer	−23.6K sh	—	—	0
2014-07-01	Forest Laboratories, LLCStock Option (Right to Buy)D Disposition to Issuer	EVP - Chief Financial Officer	DDisposition to Issuer	−88.8K sh	—	—	0
2014-07-01	Forest Laboratories, LLCStock Option (Right to Buy)D Disposition to Issuer	EVP - Chief Financial Officer	DDisposition to Issuer	−11.2K sh	—	—	0
2014-07-01	Forest Laboratories, LLCStock Option (Right to Buy)D Disposition to Issuer	EVP - Chief Financial Officer	DDisposition to Issuer	−47.5K sh	—	—	0
2014-07-01	Forest Laboratories, LLCStock Option (Right to Buy)D Disposition to Issuer	EVP - Chief Financial Officer	DDisposition to Issuer	−2,482 sh	—	—	0
2014-07-01	Forest Laboratories, LLCStock Option (Right to Buy)D Disposition to Issuer	EVP - Chief Financial Officer	DDisposition to Issuer	−73.1K sh	—	—	0
2014-07-01	Forest Laboratories, LLCStock Option (Right to Buy)D Disposition to Issuer	EVP - Chief Financial Officer	DDisposition to Issuer	−1,940 sh	—	—	0
2014-07-01	Forest Laboratories, LLCStock Option (Right to Buy)D Disposition to Issuer	EVP - Chief Financial Officer	DDisposition to Issuer	−2,684 sh	—	—	0
2014-07-01	Forest Laboratories, LLCStock Option (Right to Buy)D Disposition to Issuer	EVP - Chief Financial Officer	DDisposition to Issuer	−47.3K sh	—	—	0
2014-07-01	Forest Laboratories, LLCStock Option (Right to Buy)D Disposition to Issuer	EVP - Chief Financial Officer	DDisposition to Issuer	−4,145 sh	—	—	0
2014-07-01	Forest Laboratories, LLCStock Option (Right to Buy)D Disposition to Issuer	EVP - Chief Financial Officer	DDisposition to Issuer	−45.9K sh	—	—	0
2014-07-01	Forest Laboratories, LLCStock Option (Right to Buy)D Disposition to Issuer	EVP - Chief Financial Officer	DDisposition to Issuer	−3,198 sh	—	—	0
2014-07-01	Forest Laboratories, LLCStock Option (Right to Buy)D Disposition to Issuer	EVP - Chief Financial Officer	DDisposition to Issuer	−56.8K sh	—	—	0
2014-07-01	Forest Laboratories, LLCStock Option (Right to Buy)D Disposition to Issuer	EVP - Chief Financial Officer	DDisposition to Issuer	−75K sh	—	—	0
2014-07-01	Forest Laboratories, LLCStock Option (Right to Buy)D Disposition to Issuer	EVP - Chief Financial Officer	DDisposition to Issuer	−3,333 sh	—	—	0
2014-07-01	Forest Laboratories, LLCStock Option (Right to Buy)D Disposition to Issuer	EVP - Chief Financial Officer	DDisposition to Issuer	−71.7K sh	—	—	0
2014-07-01	Forest Laboratories, LLCStock Option (Right to Buy)D Disposition to Issuer	EVP - Chief Financial Officer	DDisposition to Issuer	−2,938 sh	—	—	0
2014-07-01	Forest Laboratories, LLCStock Option (Right to Buy)D Disposition to Issuer	EVP - Chief Financial Officer	DDisposition to Issuer	−31K sh	—	—	0
2014-07-01	Forest Laboratories, LLCStock Option (Right to Buy)D Disposition to Issuer	EVP - Chief Financial Officer	DDisposition to Issuer	−2,640 sh	—	—	0
2014-07-01	Forest Laboratories, LLCStock Option (Right to Buy)D Disposition to Issuer	EVP - Chief Financial Officer	DDisposition to Issuer	−65.2K sh	—	—	0
2014-07-01	Forest Laboratories, LLCPerformance Stock UnitsA Award	EVP - Chief Financial Officer	AAward	+32.6K sh	—	—	32,636

Recent filings

Accepted (ET)
Jul 24
Perier Francis I Jr0001104659-25-065299
SEC(opens sec.gov)
Jan 144
Perier Francis I Jr0001104659-25-003469
SEC(opens sec.gov)
Jan 74
Perier Francis I Jr0001104659-25-001774
SEC(opens sec.gov)
Jan 84
Perier Francis I Jr0001104659-24-002377
SEC(opens sec.gov)
Jan 104
Perier Francis I Jr0001104659-23-002697
SEC(opens sec.gov)
Jan 94
Perier Francis I Jr0001104659-23-002323
SEC(opens sec.gov)

Companies

Address

C/O FOREST LABORATORIES, INC. 909 THIRD AVENUE

NEW YORK, NY, 10022